We are live on
!
Find out more
BP
Ballentine Partners Portfolio holdings
AUM
$8.18B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
+2.63%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$2.08B
AUM Growth
+$162M
(+8.4%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
5.42%
Top 10 Holdings %
Top 10 Hldgs %
60.28%
Holding
408
New
78
Increased
225
Reduced
57
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$30.9M |
| 2 |
Pfizer
PFE
|
+$4.57M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$4.1M |
| 4 |
ExxonMobil
XOM
|
+$3.59M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$2.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.46M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.29M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.06M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$871K |
| 5 |
Vanguard Small-Cap ETF
VB
|
+$864K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.4% |
| 2 | Industrials | 2.28% |
| 3 | Financials | 2.13% |
| 4 | Energy | 1.92% |
| 5 | Healthcare | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Antero Midstream
AM
$10.2B
| $568K | 0.03% |
49,578
+11,130
| +29% | +$143K |
|
202
Baxter International
BAX
$12.7B
| $565K | 0.03% |
6,905
+524
| +8% | +$40.7K |
|
203
Booking.com
BKNG
$156B
| $556K | 0.03% |
7,425
+1,300
| +21% | +$93.4K |
|
204
Morgan Stanley
MS
$321B
| $556K | 0.03% |
12,707
+6,472
| +104% | +$289K |
|
205
Medtronic
MDT
$113B
| $547K | 0.03% |
5,617
+1,383
| +33% | +$126K |
|
206
Air Products & Chemicals
APD
$65.2B
| $537K | 0.03% |
2,371
-246
| -9% | -$50.9K |
|
|
SCHW
207
Charles Schwab
SCHW
$185B
| $509K | 0.02% |
12,678
+1,284
| +11% | +$56K |
|
208
Waste Management
WM
$96.7B
| $509K | 0.02% |
4,412
+636
| +17% | +$69K |
|
209
Banco Bilbao Vizcaya Argentaria
BBVA
$142B
| $506K | 0.02% |
91,047
+7,013
| +8% | +$40.8K |
|
210
Charter Communications
CHTR
$17.1B
| $501K | 0.02% |
1,268
+184
| +17% | +$69K |
|
211
State Street Technology Select Sector SPDR ETF
XLK
$109B
| $496K | 0.02% |
12,724
+2,572
| +25% | +$98.1K |
|
212
CALL
Apple
AAPL
$5.01T
| $495K | 0.02% |
+10,000
| New | +$487K |
|
213
Philip Morris
PM
$313B
| $494K | 0.02% |
6,288
+1,509
| +32% | +$125K |
|
214
Vanguard Mid-Cap Growth ETF
VOT
$18.9B
| $494K | 0.02% |
3,310
| – | – |
|
215
HSBC
HSBC
$352B
| $493K | 0.02% |
11,802
+923
| +8% | +$38.7K |
|
216
Travelers Companies
TRV
$82.2B
| $492K | 0.02% |
3,293
+393
| +14% | +$56.7K |
|
|
CNXM
217
DELISTED
CNX Midstream Partners LP
CNXM
| $487K | 0.02% |
34,630
+10,320
| +42% | +$153K |
|
218
Boston Scientific
BSX
$69.2B
| $481K | 0.02% |
11,185
+1,974
| +21% | +$75.9K |
|
219
Eli Lilly
LLY
$1.09T
| $480K | 0.02% |
4,327
+771
| +22% | +$90.8K |
|
220
Diageo
DEO
$49.7B
| $477K | 0.02% |
2,774
-34
| -1% | -$5.71K |
|
221
Vanguard Small-Cap Growth ETF
VBK
$22.6B
| $474K | 0.02% |
2,543
-56
| -2% | -$10.2K |
|
222
Broadcom
AVGO
$1.77T
| $470K | 0.02% |
16,350
+3,720
| +29% | +$108K |
|
223
Biogen
BIIB
$31.3B
| $460K | 0.02% |
1,965
+23
| +1% | +$5.31K |
|
224
Aflac
AFL
$66B
| $454K | 0.02% |
8,288
+382
| +5% | +$19.7K |
|
225
Humana
HUM
$43.6B
| $453K | 0.02% |
1,709
-9
| -0.5% | -$2.28K |
|
Similar funds
LGF
OC
CCM
CL
WJWM
WA
CCM
AIM
Ballentine Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Ballentine Partners held 408 positions worth $2.08B, up 8.4% from $1.92B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Ballentine Partners deployed $113M of net new capital in Q2 2019, opening 78 new positions and adding to 225 existing holdings. Its largest new stake was Trane Technologies: 19,794 shares worth $2.51M.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 2% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $3.46M trimmed.
- Ballentine Partners's largest Q2 2019 buy was Trane Technologies: 19,794 shares worth $2.51M.
- Ballentine Partners added most to Vanguard Total Stock Market ETF in Q2 2019, an estimated $30.9M increase.
- Ballentine Partners's biggest Q2 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $3.46M.
- Ballentine Partners fully exited Goldcorp Inc in Q2 2019, selling an estimated $483K.
- Ballentine Partners's ten largest holdings make up 60% of its $2.08B portfolio in Q2 2019.
- Ballentine Partners opened 78 new positions and closed 9 in Q2 2019.
- Ballentine Partners's portfolio value rose 8.4% quarter-over-quarter to $2.08B.
Based on Ballentine Partners's 13F filing for Q2 2019, filed 25 Jul 2019.